Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose

被引：15
作者：
Suarez-Kurtz, Guilherme [1 ]
Perini, Jamila A. [1 ]
Silva-Assuncao, Edimilson [1 ]
Struchiner, Claudio J. [1 ]
机构：
[1] Inst Nacl Canc, Div Farmacol, BR-21230050 Rio De Janeiro, Brazil
来源：
BLOOD | 2009年 / 113卷 / 17期
关键词：
POLYMORPHISMS; REQUIREMENTS;
D O I：
10.1182/blood-2009-01-200600
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4125 / 4126
页数：2
相关论文
共 50 条
  • [31] Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
    Cullell, Natalia
    Carrera, Caty
    Muino, Elena
    Torres-Aguila, Nuria-Paz
    Carcel-Marquez, Jara
    Gonzalez-Sanchez, Jonathan
    Gallego-Fabrega, Cristina
    Molina, Jessica
    Besora, Sarah
    Sotoca, Javier
    Buongiorno, Maria-Teresa
    Jimenez-Conde, Jordi
    Giralt-Steinhauer, Eva
    de Torres-Chacon, Reyes
    Montaner, Joan
    Mancha, Fernando
    Cabezas, Juan A.
    Marti-Fabregas, Joan
    Prats-Sanchez, Luis
    Camps-Renom, Pol
    Purroy, Francisco
    Cambray, Serafi
    Freijo, Maria del Mar
    Vives-Bauz, Cristofol
    Tur, Silvia
    Font, Maria-Angels
    Lopez-Cancio, Elena
    Hernandez-Perez, Maria
    Obach, Victor
    Calleja, Ana
    Arenillas, Juan
    Rodriguez-Yanez, Manuel
    Castillo, Jose
    Sobrino, Tomas
    Fernandez-Cadenas, Israel
    Krupinski, Jerzy
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen
    El Din, M. S.
    Amin, D. G.
    Ragab, S. B.
    Ashour, E. E.
    Mohamed, M. H.
    Mohamed, A. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (05) : 517 - 524
  • [33] Analysis of CYP2C9 polymorphisms (*2 and*3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR
    Yasmeen, Faiza
    Ghafoor, Muhammad Bilal
    Khalid, Abdul Wadood
    Latif, Waqas
    Mohsin, Shahida
    Khaliq, Shagufta
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (02) : 218 - 224
  • [34] Effect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals
    Benavides, Felipe
    Grossman, Nicole
    Poggi, Helena
    Nieto, Elena
    Bertran, Antonio
    Araos, Daniel
    Vasquez, Marcos
    Ibarra, Ignaz
    Caceres, Felipe
    Espinoza, Karena
    Lagos, Marcel
    Repetto M, Gabriela
    REVISTA MEDICA DE CHILE, 2015, 143 (11) : 1369 - 1376
  • [35] Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users
    Verhoef, T. I.
    Redekop, W. K.
    Buikema, M. M.
    Schalekamp, T.
    van der Meer, F. J. M.
    Le Cessie, S.
    Wessels, J. A. M.
    van Schie, R. M. F.
    De Boer, A.
    Teichert, M.
    Visser, L. E.
    Maitland-van der Zee, A. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) : 606 - 614
  • [36] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Dhakchinamoorthi Krishna Kumar
    Deepak Gopal Shewade
    Marie-Anne Loriot
    Philippe Beaune
    Jayaraman Balachander
    B. V. Sai Chandran
    Chandrasekaran Adithan
    European Journal of Clinical Pharmacology, 2014, 70 : 47 - 56
  • [37] Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes
    Howard, Rebecca
    Leathart, Julian B. S.
    French, David J.
    Krishan, Elaina
    Kohnke, Hugo
    Wadelius, Mia
    van Schie, Rianne
    Verhoef, Talitha
    Maitland-van der Zee, Anke-Hilse
    Daly, Ann K.
    Barallon, Rita
    CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2063 - 2069
  • [38] Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups
    Scott, Stuart A.
    Khasawneh, Rame
    Peter, Inga
    Kornreich, Ruth
    Desnick, Robert J.
    PHARMACOGENOMICS, 2010, 11 (06) : 781 - 791
  • [39] Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians
    Vargens, Daniela D.
    Damasceno, Albertino
    Petzl-Erler, Maria-Luiza
    Suarez-Kurtz, Guilherme
    PHARMACOGENOMICS, 2011, 12 (06) : 769 - 772
  • [40] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Farajzadeh-Dehkordi, Mahvash
    Samiee-Rad, Fatemeh
    Farzam, Seyed Saeed
    Javadi, Amir
    Cheraghi, Sara
    Hamedi-Asl, Dariush
    Rahmani, Babak
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 695 - 704
12345